Clinical trial
Heart Rate Regularization in Patients With Permanent Atrial Fibrillation Post…
NCT00246805 · Medtronic BRC, Industry · Completed
Key facts
| NCT number | NCT00246805 |
|---|---|
| Title | Heart Rate Regularization in Patients With Permanent Atrial Fibrillation Post Marketing Study |
| Official title | Post Marketing Study on Heart Rate Regularization in Patients With Permanent Atrial Fibrillation |
| Acronym | RARE-PEARL |
| Lead sponsor | Medtronic BRC, Industry |
| Collaborators | Medtronic Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Permanent Atrial Fibrillation |
| Intervention type | Device |
| Interventions | Vitatron pacemaker C20 SSIR or T20 SSIR models |
| Enrollment | 67 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Oct 31, 2005 |
| Last update posted | Sep 28, 2011 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: